Management of urinary retention due to benign prostatic hyperplasia using luteinizing hormone-releasing hormone agonist
Authors:
- Charles B. BrendlerCBCharles B. Brendler
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Response of the Benign Hypertrophied Prostate to Treatment with an LHRH AnalogueBritish Journal of Urology, 1988
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- EFFECT OF A GNRH ANALOGUE (LEUPROLIDE) ON BENIGN PROSTATIC HYPERTROPHYThe Journal of Clinical Endocrinology & Metabolism, 1987
- Benign Prostatic Hyperplasia Treated by Castration or the LH-RH Analogue Buserelin: A Report on 6 CasesEuropean Urology, 1986
- The Development of Human Benign Prostatic Hyperplasia with AgeJournal of Urology, 1984
- Prostatic hyperplasia: radiological intervention. Work in progress.Radiology, 1984
- Effects of Prazosin in Patients with Benign Prostatic ObstructionJournal of Urology, 1983
- Assessment of the Antihypercholesterolemic Drug, Probucol, in Benign Prostatic HyperplasiaJournal of Urology, 1983
- Symptomatic treatment of benign prostatic obstruction with Nicergoline: A placebo controlled clinical study and urodynamic evaluationUrological Research, 1982
- The Treatment of Benign Prostatic Hypertrophy with Flutamide (SCH 13521): A Placebo-Controlled StudyJournal of Urology, 1975